| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $9,9900 | -1,96 % | $317,37M | $61,77K | |
FUND Sprott Focus Trust, Inc. | $10,7600 | -0,09 % | $317,19M | $22,58K | |
FATE Fate Therapeutics, Inc. | $2,5350 | -1,36 % | $317,04M | $1,57M | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1,4800 | -5,13 % | $316,83M | $534,03K | |
GALT Galectin Therapeutics Inc. | $4,1550 | +0,12 % | $316,66M | $345,23K | |
NREF NexPoint Real Estate Finance, Inc. | $17,3800 | +1,11 % | $316,64M | $49,43K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10,7400 | -0,28 % | $316,34M | $1,08K | |
PSBD Palmer Square Capital BDC Inc. | $10,2700 | -0,29 % | $316,32M | $38,27K | |
| $3,1250 | -3,55 % | $316,09M | $652,70K | |
| $6,5300 | -0,91 % | $315,88M | $9,96K | |
SMTI Sanara MedTech Inc. Common Stock | $34,5800 | -0,20 % | $315,59M | $161,20K | |
MLP Maui Land & Pineapple Co. | $15,8400 | -0,94 % | $315,56M | $10,32K | |
AFB Alliance National Municipal Income Fund, Inc. | $10,9100 | -0,05 % | $315,33M | $46,49K | |
| $44,1500 | +3,35 % | $315,30M | $19,17K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10,5500 | +0,05 % | $315,30M | $50,11K | |
